Inducible nitric oxide synthase in severe human heart failure

Journal of the American College of Cardiology

Volumn 45, Issue 9, 2005, Pages 1425-1427

  Starling, Randall C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; INDUCIBLE NITRIC OXIDE SYNTHASE; INOTROPIC AGENT;

DISEASE SEVERITY; DRUG EFFECT; HEART FAILURE; HEART HEMODYNAMICS; HUMAN; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 18144365880     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.02.021     Document Type: Editorial

References (16)

1. R.D. Patten, D. DeNofrio, M. El-Zaru Ventricular assist device therapy normalizes inducible nitric oxide synthase expression and reduces cardiomyocyte apoptosis in the failing human heart J Am Coll Cardiol 45 2005 1419 1424
2. S.D. Prabhu Nitric oxide protects against pathological ventricular remodeling reconsideration of the role of NO in the failing heart Circ Res 94 2004 1155 1157
3. J. Heger, A. Godecke, U. Flogel Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction Circ Res 90 2002 93 99
4. M.M. Givertz, W.S. Colucci New targets for heart-failure therapy endothelin, inflammatory cytokines, and oxidative stress Lancet 352 1998 SI34 SI38
5. J.L. Balligand, P.J. Cannon Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences Arterioscler Thromb Vasc Biol 17 1997 1846 1858
6. A.L. Taylor, S. Ziesche, C. Yancy Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med 351 2004 2049 2057
7. G.A. Haywood, P.S. Tsao, H.E. von der Leyen Expression of inducible nitric oxide synthase in human heart failure Circulation 93 1996 1087 1094
8. C.E. Berry, J.M. Hare Xanthine oxidoreductase and cardiovascular disease molecular mechanisms and pathophysiological implications J Physiol 555 2004 589 606
9. G. Kojda, D. Harrison Interactions between NO and reactive oxygen species pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure Cardiovasc Res 43 1999 562 571
10. I.N. Mungrue, R. Gros, X. You Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death J Clin Invest 109 2002 735 743
11. C. Heymes, M. Vanderheyden, J.G.F. Bronzwaer Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy Circulation 99 1999 3009 3016
12. H. Drexler Nitric oxide synthases in the failing human heart a double-edged sword? Circulation 99 1999 2972 2975
13. M.A. Silver, D.P. Horton, J.K. Ghali, U. Elkayam Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure J Am Coll Cardiol 6 2002 798 803 39
14. M. Fukuchi, S.N. Hussain, A. Giaid Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure their relation to lesion site and beta-adrenergic receptor therapy Circulation 98 1998 132 139
15. P. Razeghi, M. Mukhopadhyay, T.J. Myers Myocardial tumor necrosis factor-alpha expression does not correlate with clinical indices of heart failure in patients on left ventricular assist device support Ann Thorac Surg 72 2001 2044 2050
16. D.M. Mancini, A. Beniaminovitz, H. Levin Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure Circulation 98 1998 2383 2389